Literature DB >> 1445102

Cardiovascular evaluation in Turner syndrome: utility of MR imaging.

K L Dawson-Falk1, A M Wright, B Bakker, P T Pitlick, D M Wilson, R G Rosenfeld.   

Abstract

Forty patients with karyotypically proven Turner syndrome were prospectively studied using magnetic resonance imaging (MRI) and echocardiography in order to determine the frequency of cardiovascular anomalies and to assess the utility of both imaging modalities as methods for cardiovascular evaluation in Turner syndrome. Cardiovascular anomalies were found in 45% of patients. A high absolute prevalence of bicuspid aortic valve (17.5%) and aortic coarctation (12.5%) were observed relative to comparable series. Of clinically significant abnormalities, three of five aortic coarctations and four of five ascending aortic dilatations were solely MRI detected and not evident at echocardiographic examination. MRI is thus seen as a valuable adjunct to echocardiography in the cardiovascular evaluation of Turner syndrome patients. The usefulness of MRI primarily relates to its ability to provide excellent visualisation of the entire thoracic aorta where a large proportion of clinically significant anomalies occur in Turner syndrome.

Entities:  

Mesh:

Year:  1992        PMID: 1445102     DOI: 10.1111/j.1440-1673.1992.tb03152.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  17 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Failure of Marfan anatomic criteria to predict risk of aortic dissection in Turner syndrome: necessity of specific adjusted risk thresholds.

Authors:  Juan-Pablo Maureira; Fabrice Vanhuyse; Malik Lekehal; Thierry Hubert; Charlène Vigouroux; Marie-Françoise Mattei; Daniel Grandmougin; Jean-Pierre Villemot
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-26

3.  Aortic dilatation in Turner syndrome: the role of MRI in early recognition.

Authors:  François Chalard; Solène Ferey; Cécile Teinturier; Gabriel Kalifa
Journal:  Pediatr Radiol       Date:  2004-12-29

Review 4.  New issues in the diagnosis and management of Turner syndrome.

Authors:  Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 5.  Syndromes with aortic involvement: pictorial review.

Authors:  Evan J Zucker
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

6.  Unreliability of aortic size index to predict risk of aortic dissection in a patient with Turner syndrome.

Authors:  Jan Nijs; Sandro Gelsomino; Fabiana Lucà; Orlando Parise; Jos G Maessen; Mark La Meir
Journal:  World J Cardiol       Date:  2014-05-26

7.  Structural and functional abnormalities of large arteries in the Turner syndrome.

Authors:  J-P Baguet; S Douchin; H Pierre; A-M Rossignol; M Bost; J-M Mallion
Journal:  Heart       Date:  2005-03-10       Impact factor: 5.994

8.  Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study.

Authors:  Britta E Hjerrild; Kristian H Mortensen; Keld E Sørensen; Erik M Pedersen; Niels H Andersen; Erik Lundorf; Klavs W Hansen; Arne Hørlyck; Alfred Hager; Jens S Christiansen; Claus H Gravholt
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-11       Impact factor: 5.364

9.  Evaluation of cardiovascular anomalies in patients with asymptomatic turner syndrome using multidetector computed tomography.

Authors:  Sun Hee Lee; Ji Mi Jung; Min Seob Song; Seok jin Choi; Woo Yeong Chung
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

10.  Aortic dimensions in girls and young women with turner syndrome: a magnetic resonance imaging study.

Authors:  Line Cleemann; Kristian H Mortensen; Kirsten Holm; Heidi Smedegaard; Sven O Skouby; Steen B Wieslander; Anne-Mette Leffers; Per Leth-Espensen; Erik Morre Pedersen; Claus H Gravholt
Journal:  Pediatr Cardiol       Date:  2010-01-10       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.